PCSC

Perceptive Capital Solutions Corp Class A Ordinary Shares
NASDAQFINANCIAL SERVICESSHELL COMPANIES

Key Statistics

Market Cap
$123.25M
P/E Ratio
EPS
$-0.07
Beta
0.36
52W High
$14.47
52W Low
$9.95
50-Day MA
$11.20
200-Day MA
$11.73
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Perceptive Capital Solutions Corp Class A Ordinary Shares

Perceptive Capital Solutions Corp (PCSC) is a forward-thinking investment management firm dedicated to uncovering and harnessing high-growth opportunities across various sectors. By employing advanced analytics and comprehensive market insights, PCSC crafts bespoke investment strategies that aim to enhance portfolio performance amidst dynamic market environments. With a strong commitment to maximizing shareholder value, the firm has positioned itself as a reliable partner for institutional investors, skillfully navigating market intricacies and capitalizing on emerging trends to generate superior returns.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-2.04%
Revenue/Share (TTM)$0.00
Book Value$-0.51
Price-to-Book1.56
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)-85.30%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$8.16M
Float$2.10M
% Insiders0.25%
% Institutions9.99%

Historical Volatility

HV 10-Day
48.27%
HV 20-Day
40.53%
HV 30-Day
33.82%
HV 60-Day
24.89%
HV Rank
81.0%

Volatility is currently expanding

Latest News

Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders

– Extraordinary General Meeting of Perceptive Shareholders Postponed to July 15, 2026 NEW YORK, July 9, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (Nasdaq: PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, announced today that the extraordinary general meeting of shareholders of PCSC (the "Extraordinary General Meeting"), originally scheduled for July 9, 2026 at 10:00 a.m. Eastern Time, to approve proposals related to the proposed business combination (the "Business Combination") between PCSC and Freenome Holdings, Inc. ("Freenome"), an early cancer detection company developing blood-based screening tests has been postponed to July 15, 2026 at 10:00 a.m.

PRNewsWire7/9/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PCSC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 7/29/2026